monoclonal

Documents about monoclonal

• Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy#897259ClinicalTrials.gov
• Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis#813014ClinicalTrials.gov
• Monoclonal Antibodies in Pediatric Atopic Dermatitis; Efficacy and Safety#478485Europe PMC
• Subarachnoid neurocysticercosis in a rural area of the Bolivian Chaco: A population-based survey through the use of a novel urine antigen assay#136441PLOS
• Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy#859660ClinicalTrials.gov
• A new pitfall in potassium testing: A case series of false elevation of hemolysis index in the presence of monoclonal protein#670012HAL (France)
• EXCIPIENTS FOR ENHANCING MONOCLONAL ANTIBODY STABILITY IN ORAL SOLID DOSAGE FORMS#288533ScholarBank@NUS
• The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma#848198ClinicalTrials.gov
• Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults#993268ClinicalTrials.gov
• Oxford Pre-cancerous Lymphoproliferative Disorders Study#804563ClinicalTrials.gov
• A Study of Anti-HIV Monoclonal Antibody KD-247#895209ClinicalTrials.gov
• Monoclonal Antibodies Accessing the Cytosol of Living Cells and Binding to Polo‐Like Kinase 1 Interdomain Linker Affect Mitotic Behavior#176828HAL (France)
• The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities.#240441PubMed
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing.#404592PubMed
• Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study#185586IRIS
• Therapeutic approaches against dengue virus: current status of vaccines, antivirals, and monoclonal antibodies.#309484PubMed
• Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS#301207HAL (France)
• A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors#885682ClinicalTrials.gov
• Study in Healthy Volunteers to Evaluate a Human Monoclonal Antibody Against Hepatitis C#908027ClinicalTrials.gov
• Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing#651931Europe PMC
• Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies#851367ClinicalTrials.gov
• Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2#907959ClinicalTrials.gov
• FC-OPTIMIZATION OF DNA-ENCODED MONOCLONAL ANTIBODIES: AN ALTERNATIVE APPROACH TO COMBATING ANTIMICROBIAL RESISTANCE#637519ScholarlyCommons at Penn
• Molecular interplay of insulin resistance and cancer: advances in monoclonal antibody therapeutics#651923Europe PMC
• Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients#893033ClinicalTrials.gov
• B-Cell Hematologic Malignancy Vaccination Registry#842477ClinicalTrials.gov
• Monoclonal Antibody CT-011 in Combination With Rituximab in Patients With Relapsed Follicular Lymphoma#803524ClinicalTrials.gov
• The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV#886687ClinicalTrials.gov
• A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis#979062ClinicalTrials.gov
• High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients#291396Gestión del Repositorio Documental de la Universidad de Salamanca
• Experimental and Computational Insight into the pH-Dependent Binding of Poly(glutamate)–Monoclonal Antibody Complexes for Biopharmaceutical Formulation#411828HAL (France)
• Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101#877145ClinicalTrials.gov
• Patient-Reported AutoImmunity Secondary to Cancer immunothErapy#889039ClinicalTrials.gov
• Combination of Steroid and Humanized CD25 Monoclonal Antibody as First-line Therapy for aGVHD#901092ClinicalTrials.gov
• Advancing SARS-CoV-2 Variant Detection with High Affinity Monoclonal Antibodies and Plasmonic Nanostructure#342289KOASAS: KAIST Open Access Self-Archiving System
• Biomarkers: monoclonal protein and indicators of cardiac damage.#185590IRIS
• A Humanized Anti-Interferon-γ Monoclonal Antibody (HuZAF) for Moderate to Severe Crohn's Disease#867560ClinicalTrials.gov
• FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors#279502ClinicalTrials.gov
• Adrecizumab-LPS Study#862341ClinicalTrials.gov
• A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)#839125ClinicalTrials.gov
• MSCs Combined With CD25 Monoclonal Antibody and Calcineurin Inhibitors for Treatment of Steroid-resistant aGVHD#874660ClinicalTrials.gov
• A Phase 1/2a Study of PGT121, VRC07-523LS and PGDM1400 Monoclonal Antibodies in HIV-uninfected and HIV-infected Adults#904364ClinicalTrials.gov
• Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3#121864HAL (France)
• Investigación del patrón de eliminación de la inmunoglobulina monoclonal mediante espectrometría de masas en pacientes con mieloma múltiple#424903Gestión del Repositorio Documental de la Universidad de Salamanca
• Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies With Early Access Authorization in Immunocompromised Patients. A Prospective Cohort.#900060ClinicalTrials.gov
• A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma#863374ClinicalTrials.gov
• SBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases#174873ClinicalTrials.gov
• Predicting Agitation Stability of Monoclonal Antibodies during Developability Assessment.#258152NCBI PubMed Central
• Monoclonal anti-dsRNA antibody-based metagenomics (MADAM) reveal Pyricularia oryzae mycovirome#314151bioRxiv / medRxiv
• EGFR Monoclonal Antibody for Advanced Gastric Cancer#857918ClinicalTrials.gov